Establishment of epitope-defined monoclonal antibodies with specificity for fibroblast growth factor receptor types 1 and 2

Hybridoma

Volumn 17, Issue 1, 1998, Pages 21-31

  Larocca, David ^a   Witte, Alison ^a   Gonzalez, Ana Maria ^a   Houston, L L ^a  

^a Prizm Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FREUND ADJUVANT; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; IMMUNOGLOBULIN G1; MONOCLONAL ANTIBODY; PARAFFIN; PRISTANE; RECEPTOR PROTEIN; RECEPTOR SUBTYPE; THIOREDOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; EPITOPE MAPPING; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYBRIDOMA; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SEQUENCE HOMOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); EUKARYOTA;

EID: 0031886362     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1998.17.21     Document Type: Article

References (41)

1. Burgess WH and Maciag T: The heparin-binding (fibroblast) growth factor family of proteins. Ann Rev Biochem 1989;58:575-606.
2. Baird A: Fibroblast growth factors: Activities and significance of non-neurotrophin neurotrophic growth factors. Curr Opin Neurobiol 1994;4:78-86.
3. Johnson DE and Williams LT: Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 1993;60: 1-41.
4. Orr-Urtreger A, Givol D, Yayon A, Yarden Y, and Lonai P: Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development 1991;113:1419-1434.
5. Emoto H, Tagashira S, Mattei MG, Yamasaki M, Hashimoto G, Katsumata T, Negoro T, Nakatsuka M, Birnbaum D, Coulier F, and Itoh N: Structure and expression of human fibroblast growth factor-10. J Biol Chem 1997;272:23191-23194.
6. Isacchi A, Bergonzoni L, and Sarmientos P: Complete sequence of a human receptor for acidic and basic fibroblast growth factors. Nucl Acids Res 1990;18:1906.
7. Dionne CA, Crumley GR, Bellot F, Kaplow JM, Searfoss G, Ruta M, Burgess WH, Jaye M, and Schlessinger J: Cloning and expression of two distinct high affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO 1990;9:2685-2692.
8. Houssaint E, Blanquet PR, Champion-Arnaud P, Gesnel MC, Torriglia A, Courtois Y, and Breathnach R: Related fibroblast growth factor receptor genes exist in the human genome. Proc Natl Acad Sci USA 1990;87:8180-8184.
9. Keegan K, Johnson DE, Williams LT, and Hayman MJ: Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA 1991;88:1095-1099.
10. Partanen J, Mäkelä TP, Eerola E, Korhonen J, Hirvonen H, Claesson-Welsh L, and Alitalo K: FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 1991;10:1347-1354.
11. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, and Goldfarb M: Receptor specificity of the fibroblast growth factor family. J Biol Chem 1996;271:15292-15297.
12. Becker D, Lee PL, Rodeck U, and Herlyn M: Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene 1992;7:2303-2313.
13. Luqmani YA, Graham M, and Coombes RC: Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Brit J Cancer 1992;66:273-280.
14. Allen LE and Maher PA: Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line. J Cell Physiol 1993;155:368-375.
15. Kobrin MS, Yamanaka Y, Friess H, Lopez ME, and Korc M: Aberrant expression of type 1 fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993;53:4741-4744.
16. Hasegawa Y, Takada M, Yamamoto M, and Saitoh Y: The gradient of basic fibroblast growth factor concentration in human pancreatic cancer cell invasion. Biochem Biophys Res Commun 1994;200:1435-1439.
17. Halaban R, Kwon BS, Ghosh S, Delli Bovis P, and Baird A: bFGF as an autocrine growth factor for human melanomas. Oncogene Res 1988;3:177-186.
18. Becker D, Meier CB, and Herlyn M: Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 1989;8: 3685-3691.
19. Wang Y and Becker D: Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nature Med 1997;3:887-893.
20. Kandel J, Bossy WE, Radvanyi F, Klagsbrun M, Folkman KJ, and Hanahan D: Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 1991;66:1095-1104.
21. Williams AF, and Barclay AN: The immunoglobulin superfamily domains for cell surface recognition. Ann Rev Immunol 1988;6: 381-405.
22. Werner S, Duan DR, deVries C, Peters KG, Johnson DE, and Williams LT: Differential splicing of the extracellular region of fibroblast growth factor receptor-1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 1992;12:82-88.
23. Dell KR, and Williams LT: A novel form of fibroblast growth factor receptor 2: Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity. J Biol Chem 1992;267:21225-21229.
24. Johnson DE, Lu J, Chen H, Werner S, and Williams LT: The human fibroblast growth factor receptor genes: A common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 1991;11:4627-4634.
25. Johnson DE, Lee PL, Lu J, and Williams LT: Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol Cell Biol 1990;10:4728-4736.
26. Sambrook J, Fritsch D, and Maniatis T. Molecular cloning: A laboratory manual. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1990.
27. Marston FAO. The purification of eucaryotic polypeptides expressed in E. coli. In: P. Glover (ed.), DNA Cloning: A Practical Approach, pp. 59-88, London: IRL Press, 1987.
28. Kiefer MC, Baird A, Nguyen T, George-Nascimento C, Mason OB, Boley LJ, Valenzuela P, and Barr P: Molecular cloning of human basic fibroblast growth factor receptor cDNA and expression of a biologically active extracellular domain in a baculovirus system. Growth Factors 1991;5:115-127.
29. de St. Groth F, and Scheidegger D: Production of monoclonal antibodies: Strategy and tactics. J Immunol Methods 1980;35:1-21.
30. Harlow E, and Lane D: Antibodies: A laboratory manual. Plainview, NY: Cold Spring Harbor Laboratory Press, 1988.
31. Reik LM, Maines SL, Ryan DE, Levin W, Bandiera S, and Thomas PE: A simple, non-chromatographic purification procedure for monoclonal antibodies. J Immunol Meth 1987;100:123-130.
32. Geysen HM, Rodda SJ, Mason TJ, Tribbick G, and Schoofs PG: Strategies for epitope analysis using peptide synthesis. J Immunol Meth 1987;102:259-274.
33. Towbin H, Staehelin T, and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76: 4350-4354.
34. Hanneken A, Maher PA, and Baird A: High affinity immunoreactive FGF receptors in the extracellular matrix off vascular endothelial cells - Implications for modulation of FGF-2. J Cell Biol 1995;128:1221-1228.
35. Torriglia A, Jeanny JC, and Blanquet PR: Immunohistochemical analysis of fibroblast growth factor receptor in bovine retina. Neurosci Lett 1994;172:125-128.
36. Xu J, Nakahara N, Crabb JW, Shi E, Matuo Y, Fraser M, Kan M, Hou J, and McKeehan WL: Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms. J Biol Chem 1992;267:17792-17803.
37. Brothers TE, Robison JG, Elliot BM, Boggs JM, Frankel AE, and Willingham MC: Upregulation of bFGF receptor expression after carotid bypass. J Surg Res 1995;58:28-32
38. Daley Sj, and Gotlieb AI: Fibroblast growth factor receptor-1 expression is associated with neointimal formation in vitro. Am J Path 1996;148:1193-1202.
39. Venkateswaran S, Blanckaert V, and Schilling M: Production of antifibroblast growth factor receptor monoclonal antibodies by in vitro immunization, hybridoma 1992;11:729-739.
40. Takanami I, Tanaka F, Hashizume T, Kikuchi K, Yamamoto Y, Yamamoto T, and Kodaira S: The basic fibroblast growth factor and its receptor in pulmonary adenocarcinomas: An investigation of their expression as prognostic markers. Eur J Cancer 1996;32A: 1504-1509.
41. LaRochelle WJ, Dirsch OR, Finch PW, Cheon H-G, May M, Marchese C, Pierce JH, and Aaronson SA: Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera. J Cell Biol 1995;129:357-366.